Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
VYNE Therapeutics Inc. | CHIEF SCIENTIFIC OFFICER | Common Stock | 133K | $251K | $1.88 | Sep 30, 2024 | Direct |
VYNE Therapeutics Inc. | CHIEF SCIENTIFIC OFFICER | Stock Option (right to buy) | 62.5K | Jan 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VYNE | VYNE Therapeutics Inc. | Sep 30, 2024 | 1 | -$205 | 4 | Oct 2, 2024 | CHIEF SCIENTIFIC OFFICER |
VYNE | VYNE Therapeutics Inc. | Jul 1, 2024 | 1 | -$265 | 4 | Jul 3, 2024 | CHIEF SCIENTIFIC OFFICER |
VYNE | VYNE Therapeutics Inc. | Apr 1, 2024 | 1 | -$484 | 4 | Apr 3, 2024 | CHIEF SCIENTIFIC OFFICER |
VYNE | VYNE Therapeutics Inc. | Jan 1, 2024 | 3 | -$358 | 4 | Jan 3, 2024 | Chief Scientific Officer |
VYNE | VYNE Therapeutics Inc. | Dec 13, 2023 | 2 | $0 | 4 | Dec 15, 2023 | Chief Scientific Officer |
VYNE | VYNE Therapeutics Inc. | Oct 2, 2023 | 1 | -$4.53K | 4 | Oct 4, 2023 | Chief Scientific Officer |
VYNE | VYNE Therapeutics Inc. | Jun 30, 2023 | 1 | -$619 | 4 | Jul 5, 2023 | Chief Scientific Officer |
VYNE | VYNE Therapeutics Inc. | Mar 31, 2023 | 1 | -$1.48K | 4 | Apr 4, 2023 | Chief Scientific Officer |
VYNE | VYNE Therapeutics Inc. | Dec 31, 2022 | 1 | -$258 | 4 | Jan 4, 2023 | Chief Scientific Officer |
VYNE | VYNE Therapeutics Inc. | Sep 30, 2022 | 1 | -$383 | 4 | Oct 4, 2022 | Chief Scientific Officer |
VYNE | VYNE Therapeutics Inc. | Jun 30, 2022 | 1 | -$669 | 4 | Jul 5, 2022 | Chief Scientific Officer |
VYNE | VYNE Therapeutics Inc. | Mar 31, 2022 | 1 | -$2.25K | 4 | Apr 4, 2022 | Chief Scientific Officer |
VYNE | VYNE Therapeutics Inc. | Mar 17, 2022 | 2 | $0 | 4 | Mar 18, 2022 | Chief Scientific Officer |
VYNE | VYNE Therapeutics Inc. | Dec 31, 2021 | 1 | -$1.28K | 4 | Jan 4, 2022 | Chief Scientific Officer |
VYNE | VYNE Therapeutics Inc. | Sep 30, 2021 | 1 | -$2.06K | 4 | Oct 1, 2021 | Chief Scientific Officer |
VYNE | VYNE Therapeutics Inc. | Sep 2, 2021 | 2 | $0 | 4 | Sep 3, 2021 | Chief Scientific Officer |
VYNE | VYNE Therapeutics Inc. | Jun 30, 2021 | 1 | -$10.8K | 4 | Jul 2, 2021 | Chief Scientific Officer |